Overview
First generation histamine H1 antagonist used in allergic rhinitis; asthma; and urticaria. It is a component of cough and cold medicines. It may cause drowsiness.
Background
First generation histamine H1 antagonist used in allergic rhinitis; asthma; and urticaria. It is a component of cough and cold medicines. It may cause drowsiness.
Indication
For the symptomatic relief of seasonal or perennial allergic rhinitis or nonallergic rhinitis; allergic conjunctivitis; and mild, uncomplicated allergic skin manifestations of urticaria and angioedema. Also used in combination with other agents for the symptomatic relief of symptoms associated with the common cold.
Associated Conditions
- Allergic Conjunctivitis (AC)
- Nasal Congestion
- Perennial Allergic Rhinitis (PAR)
- Seasonal Allergic Rhinitis
- Upper respiratory tract signs and symptoms
- Vasomotor Rhinitis
- Mild Angioedema
- Mild urticaria
- Upper respiratory discomfort
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|
No clinical trials found
No clinical trials found for this drug
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| DECONDINE TABLET | SIN09453P | TABLET, FILM COATED | 2.5 mg | 8/5/1997 | |
| ACTIHIST SYRUP | SIN10474P | SYRUP | 1.25 mg/5 ml | 11/30/1998 | |
| ACTIMIN TABLET | SIN03927P | TABLET | 2.5 mg | 3/2/1990 | |
| COUGH-EN LINCTUS | SIN08780P | ELIXIR | 1.25 mg/5 ml | 7/3/1996 | |
| DECONDINE SYRUP | SIN03181P | SYRUP | 1.25 mg/5 ml | 6/12/1989 | |
| PEACEF SYRUP 30 mg/5 ml | SIN11124P | SYRUP | 1.25 mg/5 ml | 9/25/1999 | |
| FEDAC SYRUP | SIN03193P | SYRUP | 1.25 mg/5 ml | 6/1/1989 | |
| BEACTAFED SYRUP | SIN03143P | SYRUP | 1.25 mg/5 ml | 6/7/1989 | |
| FEDAC COMPOUND LINCTUS | SIN03195P | ELIXIR | 1.25 mg/5 ml | 6/1/1989 | |
| FEDAC TABLET | SIN03116P | TABLET | 2.5 mg | 6/7/1989 |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| Triprolidine Hydrochloride Capsules | 国药准字H20010628 | 化学药品 | 胶囊剂 | 3/3/2020 | |
| Triprolidine Hydrochloride Capsules | 国药准字HC20170006 | 化学药品 | 胶囊剂 | 12/20/2021 | |
| Triprolidine Hydrochloride Tablets | 国药准字H20010629 | 化学药品 | 片剂 | 3/3/2020 |
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||